5751 related articles for article (PubMed ID: 3081484)
1. Long-term and residual melanotropin-stimulated tyrosinase activity in S91 melanoma cells is density dependent.
Abdel Malek ZA; Kreutzfeld KL; Hadley ME; Bregman MD; Hruby VJ; Meyskens FL
In Vitro Cell Dev Biol; 1986 Feb; 22(2):75-81. PubMed ID: 3081484
[TBL] [Abstract][Full Text] [Related]
2. Prolonged stimulation of S91 melanoma tyrosinase by [Nle4, D-Phe7]-substituted alpha-melanotropins.
Abdel Malek ZA; Kreutzfeld KL; Marwan MM; Hadley ME; Hruby VJ; Wilkes BC
Cancer Res; 1985 Oct; 45(10):4735-40. PubMed ID: 2992767
[TBL] [Abstract][Full Text] [Related]
3. [Nle4, D-Phe7]-alpha-MSH: a superpotent melanotropin that "irreversibly" activates melanoma tyrosinase.
Hadley ME; Abdel Malek ZA; Marwan MM; Kreutzfeld KL; Hruby VJ
Endocr Res; 1985; 11(3-4):157-70. PubMed ID: 3009169
[TBL] [Abstract][Full Text] [Related]
4. Stimulation of S91 melanoma tyrosinase activity by superpotent alpha-melanotropins.
Marwan MM; Abdel Malek ZA; Kreutzfeld KL; Hadley ME; Wilkes BC; Hruby VJ; Castrucci AM
Mol Cell Endocrinol; 1985 Jul; 41(2-3):171-7. PubMed ID: 3926559
[TBL] [Abstract][Full Text] [Related]
5. The melanotropic peptide, [Nle4,D-Phe7] alpha-MSH, stimulates human melanoma tyrosinase activity and inhibits cell proliferation.
Jiang J; Sharma SD; Nakamura S; Lai JY; Fink JL; Hruby VJ; Hadley ME
Pigment Cell Res; 1995 Dec; 8(6):314-23. PubMed ID: 8789740
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological actions of highly potent and prolonged acting biotin-labeled melanotropins.
Chaturvedi DN; Knittel JJ; Hruby VJ; Castrucci AM; Hadley ME
J Med Chem; 1984 Nov; 27(11):1406-10. PubMed ID: 6436488
[TBL] [Abstract][Full Text] [Related]
7. Actions of melanotropins on mouse melanoma cell growth in vitro.
Abdel Malek ZA; Hadley ME; Bregman MD; Meyskens FL; Hruby VJ
J Natl Cancer Inst; 1986 May; 76(5):857-63. PubMed ID: 3009949
[TBL] [Abstract][Full Text] [Related]
8. Alpha-melanocyte-stimulating hormone regulation of tyrosinase in Cloudman S-91 mouse melanoma cell cultures.
Fuller BB; Lunsford JB; Iman DS
J Biol Chem; 1987 Mar; 262(9):4024-33. PubMed ID: 3031058
[TBL] [Abstract][Full Text] [Related]
9. Effect of alpha-MSH on the tyrosinase activity and the rate of melanin accumulation of melanoma cells in vitro.
Lee TH; Lee MS
Acta Endocrinol (Copenh); 1977 Mar; 84(3):663-72. PubMed ID: 402759
[TBL] [Abstract][Full Text] [Related]
10. Decay of hormone responsiveness in mouse melanoma cells in culture as a function of cell density.
Fuller BB; Lebowitz J
J Cell Physiol; 1980 May; 103(2):279-87. PubMed ID: 6254996
[TBL] [Abstract][Full Text] [Related]
11. Potent and prolonged melanotropic activities of the alpha-MSH fragment analog, Ac-[Nle4,D-Phe7]-alpha-MSH4-9-NH2.
Klemes DG; Kreutzfeld KL; Hadley ME; Cody WL; Hruby VJ
Biochem Biophys Res Commun; 1986 Jun; 137(2):722-8. PubMed ID: 3089218
[TBL] [Abstract][Full Text] [Related]
12. The effects of pro-opiomelanocortin peptides on cyclic AMP and tyrosinase in melanoma cells.
Farah JM; Bishop JF; Nguyen HQ; O'Donohue TL
Peptides; 1986; 7(3):437-41. PubMed ID: 3022251
[TBL] [Abstract][Full Text] [Related]
13. 4-Norleucine, 7-D-phenylalanine-alpha-melanocyte-stimulating hormone: a highly potent alpha-melanotropin with ultralong biological activity.
Sawyer TK; Sanfilippo PJ; Hruby VJ; Engel MH; Heward CB; Burnett JB; Hadley ME
Proc Natl Acad Sci U S A; 1980 Oct; 77(10):5754-8. PubMed ID: 6777774
[TBL] [Abstract][Full Text] [Related]
14. Stimulation of Cloudman melanoma tyrosinase activity occurs predominantly in G2 phase of the cell cycle.
Abdel-Malek ZA; Swope VB; Trinkle LS; Nordlund JJ
Exp Cell Res; 1989 Jan; 180(1):198-208. PubMed ID: 2462505
[TBL] [Abstract][Full Text] [Related]
15. Tyrosinase activity and abundance in Cloudman melanoma cells.
Halaban R; Pomerantz SH; Marshall S; Lerner AB
Arch Biochem Biophys; 1984 Apr; 230(1):383-7. PubMed ID: 6201140
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and actions of a melanotropin conjugate, Ac-[Nle4, Glu(gamma-4'-hydroxyanilide)5, D-Phe7]alpha-MSH4-10-NH2, on melanocytes and melanoma cells in vitro.
al-Obeidi F; Mulcahy M; Pitt VS; Begay V; Hadley ME; Hruby VJ
J Pharm Sci; 1990 Jun; 79(6):500-4. PubMed ID: 2168479
[TBL] [Abstract][Full Text] [Related]
17. A new role for epidermal cell-derived thymocyte activating factor/IL-1 as an antagonist for distinct epidermal cell function.
Swope VB; Abdel-Malek ZA; Sauder DN; Nordlund JJ
J Immunol; 1989 Mar; 142(6):1943-9. PubMed ID: 2466081
[TBL] [Abstract][Full Text] [Related]
18. Cytotoxicity of 4-hydroxyanisole and tyrosinase activity in variant cell lines of B16 melanoma.
Thody AJ; Oliver I; Sherbet GV
Eur J Cancer Clin Oncol; 1988 Dec; 24(12):1879-84. PubMed ID: 2851444
[TBL] [Abstract][Full Text] [Related]
19. Regulation of tyrosinase mRNA levels in mouse melanoma cell clones by melanocyte-stimulating hormone and cyclic AMP.
Hoganson GE; Ledwitz-Rigby F; Davidson RL; Fuller BB
Somat Cell Mol Genet; 1989 May; 15(3):255-63. PubMed ID: 2543086
[TBL] [Abstract][Full Text] [Related]
20. Melanoma cells resistant to inhibition of growth by melanocyte stimulating hormone.
Pawelek J; Sansone M; Koch N; Christie G; Halaban R; Hendee J; Lerner AB; Varga JM
Proc Natl Acad Sci U S A; 1975 Mar; 72(3):951-5. PubMed ID: 165495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
